TL;DR
Gilead Advancing Access provides free Descovy and Yeztugo to uninsured patients with household income ≤500% FPL (~$75,300/year individual in 2026). No SSN required. Undocumented residents explicitly eligible. Medication ships overnight via FedEx. Apply at gileadadvancingaccess.com or 1-800-226-2056. Processing is typically 5-10 business days. Important note: Gilead ended brand Truvada assistance on January 31, 2025 — generic TDF/FTC has no manufacturer PAP equivalent.
What is Gilead Advancing Access?
Gilead Advancing Access is the patient assistance umbrella for Gilead Sciences' HIV medications. It includes two primary programs relevant to PrEP:
- Medication Assistance Program (MAP) — provides free medication to uninsured patients
- Copay Savings Program — reduces commercially insured patients' copays to $0
For PrEP, MAP covers Descovy and Yeztugo. The Copay Savings Program covers up to $7,200/year for Descovy users and up to $8,000/year + $100 per injection visit for Yeztugo users.
Who qualifies for free Descovy or Yeztugo through MAP?
Eligibility criteria for the Medication Assistance Program:
- Uninsured or underinsured: You don't have insurance that covers your PrEP prescription, or your insurance has gaps
- Income ≤500% of Federal Poverty Level: ~$75,300/year for an individual, ~$102,200 for a couple, ~$129,100 for a family of 3 in 2026
- U.S. resident: Living in the U.S. — but citizenship and immigration status are NOT required
- Social Security Number: NOT required
- Drug-specific: Program covers Descovy (oral) and Yeztugo (injectable)
The most important takeaways: there's an income ceiling (500% FPL) but it's high enough that most working-class Americans qualify. And the no-SSN, no-citizenship requirements make this program uniquely accessible for undocumented residents.
What's NOT covered (important gaps)
- Brand Truvada: Gilead stopped accepting new brand Truvada enrollments on January 31, 2025. If you were previously on brand Truvada through Advancing Access, you'd have been transitioned.
- Generic TDF/FTC: No manufacturer PAP covers generic PrEP. Options are state programs, telehealth, or cash pay.
- Apretude: Apretude is manufactured by ViiV Healthcare, not Gilead. Use ViiVConnect Patient Assistance Program for Apretude.
- Labs and clinic visits: The MAP covers medication only. Labs and visit costs may still apply unless covered through your provider.
- Government insurance: Medicare and Medicaid beneficiaries cannot use Gilead's Copay Savings Program (federal anti-kickback rules). MAP is for uninsured patients only.
Let MISTR handle Gilead Advancing Access for you
MISTR coordinates Gilead Advancing Access enrollment as part of their free PrEP signup. One intake handles everything — no separate applications, no income verification forms to fill out yourself.
Start free consultation →ANDR735
Using this code helps keep FreePrEP.org running at no cost to you. MISTR's $0 PrEP is funded through insurance reimbursement and 340B program partnerships — you pay nothing whether you have insurance or not.
Step-by-step: how to apply
Step 1: Have a PrEP prescription
You need an active PrEP prescription from a licensed provider for Descovy or Yeztugo. If you don't have a provider yet, you have options: primary care physicians, telehealth services like MISTR (which can prescribe and coordinate Gilead assistance simultaneously), sexual health clinics, FQHCs, or Ryan White clinics. Telehealth is typically the fastest path.
Step 2: Gather documentation
You'll need to verify income. Acceptable documents include:
- Most recent tax return (1040)
- Two most recent pay stubs
- W-2 or 1099 forms
- Written statement of income if self-employed or cash-based
If you can't provide these, call 1-800-226-2056 — Gilead has processes for documenting income in non-traditional ways.
Step 3: Submit application
Three ways to apply:
- Online: gileadadvancingaccess.com — fill out patient and provider sections. Your provider needs to co-sign.
- Phone: 1-800-226-2056 — Gilead representatives walk you through application
- Through your prescriber: Many providers have experience with Advancing Access and can handle the application on your behalf
- Through a telehealth platform: Services like MISTR handle Gilead Advancing Access enrollment as part of their signup
Step 4: Wait for approval (5-10 business days typically)
Processing times vary but are generally quick. Urgent cases (PEP situations, active exposure risk) can be expedited.
Step 5: Receive medication
Approved patients receive free medication via FedEx overnight shipping — to a home address, clinic, shelter, or FedEx pickup location. You choose.
Step 6: Annual renewal
Every 12 months, you'll need to re-verify income. Gilead typically sends a reminder before your renewal is due.
Let MISTR handle the Gilead paperwork
Applying to Gilead Advancing Access yourself involves forms, income verification, and provider coordination. MISTR handles all of that as part of their signup — you fill out one intake, they manage the Gilead enrollment on your behalf.
Get started with MISTR →ANDR735
Tips for getting approved faster
- Be thorough with income documentation. Missing or incomplete income documentation is the most common reason for delays.
- Have a prescriber on board. If you're applying online, your prescriber needs to co-sign — confirm with them before submitting.
- Call if you haven't heard in 10 business days. 1-800-226-2056 — status updates are available by phone.
- Use a telehealth platform to streamline. Services like MISTR handle Gilead application as part of their signup — faster than DIY.
Commercial insurance: the Copay Savings Program
If you have commercial insurance but are paying copays for Descovy or Yeztugo, the Copay Savings Program can reduce those to $0. No income restriction for this program — it's available to all commercially insured patients (excluding Medicare, Medicaid, and other government insurance).
- Enroll at prep.advancingaccess.com/orals (Descovy) or through gileadadvancingaccess.com (Yeztugo)
- Descovy: up to $7,200/year in copay coverage
- Yeztugo: up to $8,000/year in copay coverage + $100 per injection visit
Skip the application — start PrEP today
Rather than waiting 5-10 days for Gilead approval, MISTR can start you on PrEP within 3-7 days through their 340B partnerships. Gilead assistance is coordinated behind the scenes if needed.
Get started with MISTR →ANDR735
Frequently asked questions
How long does Gilead Advancing Access take to approve?
Typical processing is 5-10 business days. Urgent requests (especially for PEP) can be processed in as little as 5-10 minutes through an expedited pathway that your provider initiates by calling Gilead directly.
Do I need a Social Security Number for Gilead Advancing Access?
No. Gilead Advancing Access explicitly does not require a Social Security Number. Undocumented residents are eligible.
What's the income limit for Gilead's PrEP program?
500% of the Federal Poverty Level. In 2026, that's approximately $75,300/year for an individual, $102,200 for a couple, $129,100 for a family of 3, $156,000 for a family of 4.
Can I get free brand Truvada through Gilead?
No, not anymore. Gilead ended brand Truvada through Advancing Access on January 31, 2025, citing widespread generic availability. Options are now: generic TDF/FTC (cash ~$30/month or via state PrEP DAPs), Descovy through Advancing Access, or telehealth platforms for $0 access.
Does Gilead ship free medication?
Yes. Approved patients receive medication via FedEx overnight shipping to a home address, clinic, shelter, or FedEx pickup location.
Can I apply to Gilead Advancing Access through MISTR?
Yes. MISTR and other telehealth platforms handle Gilead Advancing Access enrollment as part of their signup process. This is typically faster and less paperwork-heavy than applying directly to Gilead.
Does the Copay Savings Program work for Medicare?
No. Federal anti-kickback rules prohibit pharmaceutical manufacturers from offering copay assistance to Medicare, Medicaid, Tricare, VA, or other government insurance beneficiaries. For Medicare beneficiaries, look at Good Days Foundation or state pharmaceutical assistance programs instead.